Elsevier

Biological Psychiatry

Volume 42, Issue 4, 15 August 1997, Pages 260-266
Biological Psychiatry

Effects of clozapine on sleep: A longitudinal study

https://doi.org/10.1016/S0006-3223(96)00347-2Get rights and content

Polysomnographic studies on the effects of clozapine, an atypical antipsychotic agent with strong sedative properties, on night sleep report inconsistent results. Most of these studies did not include baseline recordings and were not controlled for clozapine-induced fever, which is known to alter nocturnal sleep. We conducted a 2-week longitudinal polysomnographic investigation in 10 long-term drug-free schizophrenic patients prior to and at the end of the first and second weeks of clozapine treatment. Rectal temperature was measured daily and patients with fever (> 37.9°C) were excluded. Clozapine significantly improved sleep continuity. In addition, non-rapid eye movement (NREM) sleep and in particular stage 2 sleep increased significantly, while the amounts of stage 4 and slow-wave sleep decreased significantly. Clozapine increased significantly REM density, but it did not affect the amount of REM sleep. We conclude that in patients who do not experience clozapine-induced fever, clozapine has strong sleep consolidating effects resulting from an increase in stage 2 NREM sleep.

References (34)

  • American Psychiatric Association
  • AngstJ et al.

    Das klinische Wirkungsbild von Clozapin (Untersuchung mit dem AMP-System)

    Pharmakopsychiatrie

    (1971)
  • BaldessariniRJ et al.

    Clozapine, a novel antipsychotic agent

    N Engl J Med

    (1991)
  • BlumA et al.

    Marked increase in REM sleep produced by a new antipsychotic compound

    Clin Electrophysiol

    (1973)
  • BlumA et al.

    Temperaturanstiege und Bluteiweissveränderungen unter der Therapie mit Neuroleptika—unter besonderer Berücksichtigung des neuartigen Dibenzodiazepin-Derivates Clozapin

    Pharmakopsychiatrie

    (1972)
  • CowardDM

    General pharmacology of clozapine

    Br J Psychiatry

    (1992)
  • DriverHS et al.

    The influence of ipsaspirone, a 5-HT1A agonist, on sleep patterns of healthy subjects

    Psychopharmacology

    (1995)
  • Cited by (90)

    • Spared and impaired sleep-dependent memory consolidation in schizophrenia

      2018, Schizophrenia Research
      Citation Excerpt :

      APDs are sedating and may also have contributed to the longer sleep times reported by SZ patients. Chronic use of APDs tends to normalize sleep architecture (Hinze-Selch et al., 1997; Krystal et al., 2008; Maixner et al., 1998; Taylor et al., 1991), and withdrawal is associated with a progressive deterioration of sleep quality (Nofzinger et al., 1993), but their effects on the spectral content of sleep, including spindles, is largely unexplored. Previous findings that early course antipsychotic-naïve patients with SZ and non-psychotic first-degree relatives of SZ patients have spindle deficits that correlate with cognitive performance make it unlikely that the spindle deficits and consequent memory consolidation deficits are due to chronicity or treatment with APDs (Manoach et al., 2014; Schilling et al., 2017).

    • Adverse Effects of Psychotropic Medications on Sleep

      2016, Psychiatric Clinics of North America
      Citation Excerpt :

      Studies evaluating the effects of typical antipsychotic drugs in patients with schizophrenia are limited. Of the studies that are available,43–45 haloperidol, thiothixene, and flupentixol possibly reduce stage 2 sleep latency, increase TST and sleep efficiency, and significantly increase REM latency. SWS seems to remain unaffected.

    View all citing articles on Scopus
    View full text